- Report
- January 2026
- 179 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 334 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 149 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 271 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 175 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 485 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 475 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 477 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 185 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 368 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 240 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 371 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 286 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more